Metis Global Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.84M Sell
7,341
-1,268
-15% -$470K 0.06% 228
2026
Q1
$2.52M Sell
8,609
-908
-10% -$298K 0.06% 248
2025
Q4
$3.34M Sell
9,517
-705
-7% -$238K 0.08% 213
2025
Q3
$3.3M Sell
10,222
-514
-5% -$160K 0.08% 220
2025
Q2
$4.18M Sell
10,736
-1,205
-10% -$485K 0.11% 162
2025
Q1
$5.19M Buy
11,941
+1,495
+14% +$600K 0.15% 122
2024
Q4
$3.85M Sell
10,446
-1,618
-13% -$677K 0.12% 148
2024
Q3
$6.27M Buy
12,064
+992
+9% +$530K 0.2% 85
2024
Q2
$6M Buy
11,072
+216
+2% +$114K 0.21% 75
2024
Q1
$5.63M Buy
10,856
+36
+0.3% +$17.9K 0.2% 78
2023
Q4
$5.1M Sell
10,820
-721
-6% -$333K 0.2% 85
2023
Q3
$5.03M Buy
11,541
+1,626
+16% +$738K 0.24% 72
2023
Q2
$4.41M Buy
9,915
+88
+0.9% +$40.6K 0.24% 81
2023
Q1
$4.52M Buy
9,827
+2,116
+27% +$1.01M 0.29% 69
2022
Q4
$3.96M Buy
7,711
+3,412
+79% +$1.73M 0.35% 60
2022
Q3
$1.95M Buy
4,299
+295
+7% +$141K 0.31% 68
2022
Q2
$1.93M Buy
4,004
+172
+4% +$85.1K 0.31% 73
2022
Q1
$1.88M Buy
3,832
+1,707
+80% +$780K 0.23% 86
2021
Q4
$985K Buy
+2,125
New +$894K 0.27% 84

Other funds holding ELV

Metis Global Partners's ELV Position: Q2 2026 in Review

Metis Global Partners reduced its Elevance Health (ELV) stake by 15% in Q2 2026, selling an estimated $470K and leaving 7,341 shares worth $2.84M. The position accounts for 0.06% of the portfolio, ranked #228.

Metis Global Partners first reported a position in ELV in Q4 2021 and has held it in 19 quarters since. The position peaked at $6.27M in Q3 2024. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Metis Global Partners held 7,341 shares of Elevance Health worth $2.84M as of Q2 2026.
  • Metis Global Partners sold 1,268 Elevance Health shares in Q2 2026, an estimated $470K.
  • Elevance Health made up 0.06% of Metis Global Partners's portfolio in Q2 2026, its #228 holding.
  • Metis Global Partners first reported a position in Elevance Health in Q4 2021 and has held it in 19 quarters since.
  • Metis Global Partners's Elevance Health position peaked at $6.27M in Q3 2024.
  • 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Metis Global Partners's 13F filing for Q2 2026, filed 10 Aug 2026.